On these pages, you will find all relevant investment data and tools, stock exchange announcements, investor presentations, financials, key figures and reports.
20 April 2016
Q1 sales growth as expected; 2016 full-year organic sales growth and net profit outlook maintained
01 April 2016
Novozymes hereby announces that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds 5.04% of the B shares in Novozymes
30 March 2016
With reference to company announcement no. 8/2016, a reduction of the company’s B common stock by DKK 6,000,000 via cancellation of 3,000,000 treasury B stocks, was adopted at
Novozymes A/S’ Annual Shareholders’ Meeting on February 24, 2016.
29 March 2016
Novozymes hereby announces that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes.
24 February 2016
Today, Novozymes A/S held its Annual Shareholders’ Meeting. The following were decided:
12 February 2016
Novozymes informs that Eivind Kolding will not seek election to the Board of Directors at the upcoming annual shareholders’ meeting February 24, 2016, as otherwise announced in the notice to the annual shareholders’ meeting.
08 February 2016
Today, Novozymes announces the formation of three divisions: Household Care & Technical Industries, Agriculture & Bioenergy and Food & Beverages.
19 January 2016
Solid financial results in 2015; 2016 outlook of 8-10% growth in net profit despite expectations of a challenging year for sales growth
22 October 2015
9M sales and profit in line with August expectations; full-year outlook narrowed
06 August 2015
Full-year profit outlook maintained. Sales growth expectations revised
Visit archive to view all company announcements
Novozymes Saphera® enables new innovation in lactose-free, fermented dairy products.
March 31 2016
Former Secretary General of NATO Anders Fogh Rasmussen and Novozymes’ CEO take steps to highlight Europe’s problematic addiction to oil – and what can be done about it
February 3 2016
The product Alterion is based on beneficial bacteria that improve feed utilization and provide a natural alternative to antibiotic growth promoters on poultry farms.
January 25 2016
| Copyright © 2016 Novozymes. All Rights Reserved.